Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia

Author:

Vayman E. E.1ORCID,Shnayder N. A.1ORCID,Neznanov N. G.1ORCID,Nasyrova R. F.1ORCID

Affiliation:

1. Bekhterev National Medical Research Center (NMRC) of Psychiatry and Neurology

Abstract

Purpose.To analyze the results of classical and modern studies reflecting the pathophysiological mechanisms of antipsychotic-induced tardive dyskinesia.Materials and methods. We searched for full-text publications in Russian and English in the databases of E-Library, PubMed, Web of Science and Springer published over the past decade, using keywords (tardive dyskinesia (TD), drug-induced tardive dyskinesia, antipsychotics (AP), neuroleptics, typical antipsychotics, atypical antipsychotics, pathophysiology, etiology and combinations of these words). In addition, the review included earlier publications of historical interest.Results. The lecture proposed theories of development of AP-induced TD, examining its effect on dopaminergic receptors, dopaminergic neurons, neurons of the basal ganglia, and other theories: activation of estrogen receptors, disorders of melatonin metabolism, disorders of the endogenous opioid system, oxidative stress with predominant oxidation processes, blockade of 5-HT2-receptors, a decrease in the pyridoxine level, genetic predisposition, interaction of AP with the brain trace element – iron, carbonyl stress and immune inflammation and the role of the neurotrophic factor.Conclusion. The disclosure of the mechanisms of AP-induced TD will allow the development of a strategy for personalized prevention and therapy of the considered neurological complication of the AP-therapy for schizophrenia in real clinical practice. 

Publisher

Siberian State Medical University

Subject

Molecular Medicine

Reference69 articles.

1. Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Publ., 2013.

2. Cornett E.M., Novitch M., Kaye A.D., Kata V., Kaye A.M. Medication-induced tardive dyskinesia: a review and update. Ochsner J. 2017; 17 (2): 162–174. PubMed PMID: 28638290 DOI: 10.1043/TOJ-16-0108.

3. Khublarova L.A., Zakharov D.V., Mikhaylov V.A. Stratification of the risk of developing tardive drug-induced complications. Review of Psychiatry and Neurology. 2017; 4: 111–114 (in Russ.).

4. Khublarova L.A., Zakharov D.V., Mikhaylov V.A. Dynamics of quality of life indicators in patients with tardive neuroleptic dyskinesias in the process of botulinum therapy. Review of Psychiatry and Neurology. 2016; 4; 86–91 (in Russ.).

5. Kornetova E.G., Semke A.V., Dmitrieva E.G., Borodyuk Yu.N., Boyko A.S. Clinical and social risk factors of tardive dyskinesia in patients with schizophrenia during antipsychotic treatment. Bulletin of Siberian Medicine. 2015; 14 (1): 32–39 (in Russ.). DOI: 10.20538/1682-0363-2015-1-32-39.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3